From the Research
For tea dust inhalation, the recommended treatment includes removing the person from the exposure area and providing supportive care, with short-acting bronchodilators such as albuterol and oral corticosteroids like prednisone being considered for respiratory symptoms and inflammation, respectively, as supported by recent studies 1, 2. The treatment approach should prioritize removing the individual from the exposure area to prevent further inhalation of tea dust particles. Initially, ensuring the patient has access to fresh air and monitoring their breathing is crucial.
- For mild symptoms like coughing or mild irritation, no specific medication may be needed beyond rest and hydration.
- If respiratory symptoms develop, short-acting bronchodilators such as albuterol (2 puffs every 4-6 hours as needed) can help relieve bronchospasm, as indicated by studies on respiratory distress management 1.
- For inflammation, a short course of oral corticosteroids like prednisone (40-60mg daily for 5 days) may be prescribed, considering the anti-inflammatory effects of corticosteroids in respiratory conditions 2.
- Antihistamines such as cetirizine (10mg daily) can help with allergic symptoms, although their use should be tailored to the individual's response and the presence of allergic reactions. Severe cases may require oxygen therapy or hospital admission, especially if there are signs of severe respiratory distress or failure, as outlined in guidelines for managing acute severe asthma 2. Long-term management includes avoiding further tea dust exposure and using respiratory protection if exposure is unavoidable, highlighting the importance of preventive measures in occupational settings 3. These treatments address the inflammatory and allergic responses that can occur when fine tea dust particles irritate the respiratory tract, potentially causing occupational asthma or hypersensitivity pneumonitis in chronic cases, as suggested by studies on the health effects of tea dust exposure 3, 4.